Clinical Trials Browser

NIH × Stomach Neoplasms × Sorafenib × Clear all

NCT00253370 2014-11-24

Sorafenib, Docetaxel, and Cisplatin in Treating Patients With Metastatic or Advanced Gastric or Gastroesophageal Junction Cancer

Phase 2 Completed

44 enrolled 8 charts

Gastrointestinal

Stomach Neoplasms